WO1996016938A1 - Derive d'indole - Google Patents
Derive d'indole Download PDFInfo
- Publication number
- WO1996016938A1 WO1996016938A1 PCT/JP1995/002400 JP9502400W WO9616938A1 WO 1996016938 A1 WO1996016938 A1 WO 1996016938A1 JP 9502400 W JP9502400 W JP 9502400W WO 9616938 A1 WO9616938 A1 WO 9616938A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- salt
- same
- represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Claims
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9509827A BR9509827A (pt) | 1994-11-29 | 1995-11-27 | Derivados de indol |
PL95320461A PL181963B1 (pl) | 1994-11-29 | 1995-11-27 | Nowe pochodne indolu, kompozycja farmaceutyczna zawierajaca nowe pochodne indolu oraz sposób wytwarzania nowych pochodnych indolu PL PL PL |
RO97-00967A RO118426B1 (ro) | 1994-11-29 | 1995-11-27 | Derivati de indol utilizati pentru tratarea diabetului zaharat si a obezitatii |
US08/836,983 US5817689A (en) | 1994-11-29 | 1995-11-27 | Indole derivatives having a 2-phenyl-ethanolamino-substituted lower alkyl group at the 2-or 3-position thereof |
DK95937182T DK0801059T3 (da) | 1994-11-29 | 1995-11-27 | Indolderivat |
SI9530519T SI0801059T1 (en) | 1994-11-29 | 1995-11-27 | Indole derivative |
AT95937182T ATE202559T1 (de) | 1994-11-29 | 1995-11-27 | Indolderivat |
SK656-97A SK281865B6 (sk) | 1994-11-29 | 1995-11-27 | Indolový derivát a jeho optický izomér, spôsob jeho prípravy a farmaceutický prostriedok |
EP95937182A EP0801059B1 (en) | 1994-11-29 | 1995-11-27 | Indole derivative |
JP08518575A JP3100165B2 (ja) | 1994-11-29 | 1995-11-27 | インドール誘導体 |
AU39366/95A AU688165B2 (en) | 1994-11-29 | 1995-11-27 | Indole derivative |
NZ295749A NZ295749A (en) | 1994-11-29 | 1995-11-27 | Indole derivatives; preparation and medicaments for treating obesity and diabetes mellitus |
CZ19971655A CZ290871B6 (cs) | 1994-11-29 | 1995-11-27 | Indolový derivát, farmaceutický prostředek jej obsahující a způsob přípravy tohoto derivátu |
DE69521529T DE69521529T2 (de) | 1994-11-29 | 1995-11-27 | Indolderivat |
RU97110664A RU2137759C1 (ru) | 1994-11-29 | 1995-11-27 | Производное индола |
MXPA/A/1997/003858A MXPA97003858A (en) | 1994-11-29 | 1997-05-26 | Derived from in |
NO972427A NO309648B1 (no) | 1994-11-29 | 1997-05-28 | Indolderivat og farmasöytisk preparat inneholdende dette |
FI972275A FI972275A (fi) | 1994-11-29 | 1997-05-29 | Indolijohdannainen |
HK98103026A HK1003886A1 (en) | 1994-11-29 | 1998-04-09 | Indole derivative |
GR20010400309T GR3036148T3 (en) | 1994-11-29 | 2001-06-28 | Indole derivative |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6/321402 | 1994-11-29 | ||
JP06321402 | 1994-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996016938A1 true WO1996016938A1 (fr) | 1996-06-06 |
Family
ID=18132155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1995/002400 WO1996016938A1 (fr) | 1994-11-29 | 1995-11-27 | Derive d'indole |
Country Status (29)
Country | Link |
---|---|
US (1) | US5817689A (ja) |
EP (1) | EP0801059B1 (ja) |
JP (1) | JP3100165B2 (ja) |
KR (1) | KR100388747B1 (ja) |
CN (1) | CN1070477C (ja) |
AT (1) | ATE202559T1 (ja) |
AU (1) | AU688165B2 (ja) |
BR (1) | BR9509827A (ja) |
CA (1) | CA2206307A1 (ja) |
CY (1) | CY2247B1 (ja) |
CZ (1) | CZ290871B6 (ja) |
DE (1) | DE69521529T2 (ja) |
DK (1) | DK0801059T3 (ja) |
ES (1) | ES2159648T3 (ja) |
FI (1) | FI972275A (ja) |
GR (1) | GR3036148T3 (ja) |
HK (1) | HK1003886A1 (ja) |
HU (1) | HUT77308A (ja) |
IL (1) | IL116178A (ja) |
NO (1) | NO309648B1 (ja) |
NZ (1) | NZ295749A (ja) |
PL (1) | PL181963B1 (ja) |
PT (1) | PT801059E (ja) |
RO (1) | RO118426B1 (ja) |
RU (1) | RU2137759C1 (ja) |
SK (1) | SK281865B6 (ja) |
TW (1) | TW349091B (ja) |
WO (1) | WO1996016938A1 (ja) |
ZA (1) | ZA9510130B (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017513A3 (en) * | 1999-09-03 | 2001-09-20 | Takeda Chemical Industries Ltd | Pharmaceutical composition comprising an insulin sensitizer |
WO2002064133A1 (fr) * | 2001-02-16 | 2002-08-22 | Dainippon Pharmaceutical Co., Ltd. | Preparations permettant de reguler une concentration dans le sang |
WO2003106418A1 (ja) * | 2002-06-01 | 2003-12-24 | 住友製薬株式会社 | インドール、インダゾール、およびベンズアゾール類 |
WO2004089936A1 (ja) * | 2003-04-10 | 2004-10-21 | Dainippon Pharmaceutical Co., Ltd. | ヘテロアリールスルホン酸アニリド誘導体及びそれを含有する医薬組成物 |
US7803944B2 (en) | 2001-07-25 | 2010-09-28 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7879851B2 (en) | 2004-02-20 | 2011-02-01 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
WO2014033343A1 (es) | 2012-08-29 | 2014-03-06 | Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (Cnic) | Agonistas de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
WO2015199097A1 (ja) * | 2014-06-24 | 2015-12-30 | 花王株式会社 | Ucp-1発現促進剤 |
JP2016027012A (ja) * | 2014-06-24 | 2016-02-18 | 花王株式会社 | Ucp−1発現促進剤 |
US10758519B2 (en) | 2014-06-24 | 2020-09-01 | Kao Corporation | UCP-1 expression promoter |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL356468A1 (en) * | 1999-11-30 | 2004-06-28 | Dainippon Pharmaceutical Co, Ltd. | Solid preparation |
US6458824B1 (en) * | 1999-11-30 | 2002-10-01 | Dainippon Pharmaceutical Co., Ltd. | Solid preparation |
WO2003092614A2 (en) * | 2002-05-02 | 2003-11-13 | Hickle Randall S | Lipid removal from the body |
EP1927594A1 (en) * | 2003-01-14 | 2008-06-04 | Arena Pharmaceuticals, Inc. | 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
DK1599468T3 (da) * | 2003-01-14 | 2008-02-04 | Arena Pharm Inc | 1,2,3-trisubstituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser forbundet dermed såsom diabetes og hyperglykæmi |
US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
EP1915378A4 (en) * | 2005-08-12 | 2009-07-22 | Boehringer Ingelheim Int | VIRUS POLYMERASE INHIBITORS |
SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP3242666A1 (en) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06345731A (ja) * | 1992-04-28 | 1994-12-20 | Dainippon Pharmaceut Co Ltd | 2−〔2−(インドール−3−イル)エチルアミノ〕−1−フェニルエタノール誘導体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB861428A (en) * | 1958-07-14 | 1961-02-22 | Searle & Co | Improvements in or relating to indole derivatives |
US4055658A (en) * | 1976-05-17 | 1977-10-25 | Mead Johnson & Company | Cyanomethylphenethanolamines |
ATE1994T1 (de) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. |
FR2541999B1 (fr) * | 1983-03-04 | 1986-09-19 | Bristol Myers Co | Phenethanolamines et leurs utilisations |
JPH0634531A (ja) * | 1992-07-14 | 1994-02-08 | Yokogawa Electric Corp | 赤外線水分計 |
-
1995
- 1995-11-27 CN CN95197471A patent/CN1070477C/zh not_active Expired - Fee Related
- 1995-11-27 DE DE69521529T patent/DE69521529T2/de not_active Expired - Lifetime
- 1995-11-27 PL PL95320461A patent/PL181963B1/pl not_active IP Right Cessation
- 1995-11-27 AT AT95937182T patent/ATE202559T1/de not_active IP Right Cessation
- 1995-11-27 WO PCT/JP1995/002400 patent/WO1996016938A1/ja active IP Right Grant
- 1995-11-27 SK SK656-97A patent/SK281865B6/sk unknown
- 1995-11-27 TW TW084112608A patent/TW349091B/zh not_active IP Right Cessation
- 1995-11-27 PT PT95937182T patent/PT801059E/pt unknown
- 1995-11-27 US US08/836,983 patent/US5817689A/en not_active Expired - Lifetime
- 1995-11-27 RU RU97110664A patent/RU2137759C1/ru not_active IP Right Cessation
- 1995-11-27 KR KR1019970703537A patent/KR100388747B1/ko not_active IP Right Cessation
- 1995-11-27 RO RO97-00967A patent/RO118426B1/ro unknown
- 1995-11-27 ES ES95937182T patent/ES2159648T3/es not_active Expired - Lifetime
- 1995-11-27 DK DK95937182T patent/DK0801059T3/da active
- 1995-11-27 NZ NZ295749A patent/NZ295749A/en unknown
- 1995-11-27 BR BR9509827A patent/BR9509827A/pt not_active Application Discontinuation
- 1995-11-27 EP EP95937182A patent/EP0801059B1/en not_active Expired - Lifetime
- 1995-11-27 AU AU39366/95A patent/AU688165B2/en not_active Ceased
- 1995-11-27 JP JP08518575A patent/JP3100165B2/ja not_active Expired - Fee Related
- 1995-11-27 CZ CZ19971655A patent/CZ290871B6/cs not_active IP Right Cessation
- 1995-11-27 HU HU9701807A patent/HUT77308A/hu unknown
- 1995-11-27 CA CA002206307A patent/CA2206307A1/en not_active Abandoned
- 1995-11-28 IL IL11617895A patent/IL116178A/xx not_active IP Right Cessation
- 1995-11-29 ZA ZA9510130A patent/ZA9510130B/xx unknown
-
1997
- 1997-05-28 NO NO972427A patent/NO309648B1/no not_active IP Right Cessation
- 1997-05-29 FI FI972275A patent/FI972275A/fi not_active Application Discontinuation
-
1998
- 1998-04-09 HK HK98103026A patent/HK1003886A1/xx not_active IP Right Cessation
-
2001
- 2001-06-28 GR GR20010400309T patent/GR3036148T3/el not_active IP Right Cessation
- 2001-11-20 CY CY0100039A patent/CY2247B1/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06345731A (ja) * | 1992-04-28 | 1994-12-20 | Dainippon Pharmaceut Co Ltd | 2−〔2−(インドール−3−イル)エチルアミノ〕−1−フェニルエタノール誘導体 |
Non-Patent Citations (1)
Title |
---|
ARM. KHIM. ZH., 40(10), 655-9, (1987). * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001017513A3 (en) * | 1999-09-03 | 2001-09-20 | Takeda Chemical Industries Ltd | Pharmaceutical composition comprising an insulin sensitizer |
WO2002064133A1 (fr) * | 2001-02-16 | 2002-08-22 | Dainippon Pharmaceutical Co., Ltd. | Preparations permettant de reguler une concentration dans le sang |
US7803944B2 (en) | 2001-07-25 | 2010-09-28 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
WO2003106418A1 (ja) * | 2002-06-01 | 2003-12-24 | 住友製薬株式会社 | インドール、インダゾール、およびベンズアゾール類 |
JPWO2003106418A1 (ja) * | 2002-06-12 | 2005-10-13 | 住友製薬株式会社 | インドール、インダゾール、およびベンズアゾール類 |
WO2004089936A1 (ja) * | 2003-04-10 | 2004-10-21 | Dainippon Pharmaceutical Co., Ltd. | ヘテロアリールスルホン酸アニリド誘導体及びそれを含有する医薬組成物 |
US7879851B2 (en) | 2004-02-20 | 2011-02-01 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US8030309B2 (en) | 2004-02-20 | 2011-10-04 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
WO2014033343A1 (es) | 2012-08-29 | 2014-03-06 | Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (Cnic) | Agonistas de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
WO2015199097A1 (ja) * | 2014-06-24 | 2015-12-30 | 花王株式会社 | Ucp-1発現促進剤 |
JP2016027012A (ja) * | 2014-06-24 | 2016-02-18 | 花王株式会社 | Ucp−1発現促進剤 |
US10758519B2 (en) | 2014-06-24 | 2020-09-01 | Kao Corporation | UCP-1 expression promoter |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996016938A1 (fr) | Derive d'indole | |
JP2972347B2 (ja) | エストロゲン作用薬/拮抗薬 | |
JP4445504B2 (ja) | Dpp−iv阻害剤としてのヘキサヒドロピリドイソキノリン | |
KR940007739B1 (ko) | 지질분해 활성을 갖는 신규 페닐에탄올 아미노테트랄린의 제조방법 | |
JP3346562B2 (ja) | Pcpレセプター・リガンドおよびそれらを含む薬剤 | |
EP1831173B1 (en) | Tetrahydroisoquinoline compounds for treatment of cns disorders | |
JPH11514635A (ja) | ファルネシルトランスフェラーゼ阻害性2−キノロン誘導体 | |
JP4974439B2 (ja) | ファルネシルトランスフェラーゼを阻害する6−ヘテロシクリルメチルキノリノン誘導体 | |
WO1997028130A1 (fr) | Derives de l'isoquinoline et medicaments associes | |
JPH08165276A (ja) | 2−アルキルアミノ−1−フェニルエタノール誘導体 | |
EP0422666A2 (en) | 6-Substituted-1,2,3,4-tetrahydroisoquinolines | |
AU2197300A (en) | Morpholinone and morpholine derivatives and uses thereof | |
US6706716B2 (en) | Compounds specific for the human α1d adrenergic receptor and uses thereof | |
JPH0753376A (ja) | 強迫疾患の治療用医薬を製造するためのn−(ピリジニル)−1h−インドール−1−アミンの使用 | |
JP2003055344A (ja) | 3,7−ジ置換インドール誘導体及びそれを含有する医薬組成物 | |
MXPA97003858A (en) | Derived from in | |
WO1996016038A1 (fr) | Derive de 2-[2-(indol-3-yl)ethylamino]-1-phenylethanol | |
CA2225156C (en) | Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents | |
JPH06345731A (ja) | 2−〔2−(インドール−3−イル)エチルアミノ〕−1−フェニルエタノール誘導体 | |
JP2001039948A (ja) | 3,7−ジ置換インドール誘導体及びそれを含有する医薬組成物 | |
JPH08231504A (ja) | 2−(2−インドリルエチルアミノ)−1−(3−置換フェニル)エタノール誘導体 | |
WO2002016350A1 (fr) | Dérivés amines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 95197471.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KR KZ LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 65697 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/003858 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970703537 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2206307 Country of ref document: CA Ref document number: 2206307 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 295749 Country of ref document: NZ Ref document number: PV1997-1655 Country of ref document: CZ Ref document number: 97-00967 Country of ref document: RO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08836983 Country of ref document: US Ref document number: 972275 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995937182 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1199700586 Country of ref document: VN |
|
WWP | Wipo information: published in national office |
Ref document number: 1995937182 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1997-1655 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970703537 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995937182 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1997-1655 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970703537 Country of ref document: KR |